Oxford Biomedica and Sigma-Aldrich win key ruling in open biosystems patent infringement dispute

29-Oct-2007

Oxford BioMedica and Sigma-Aldrich announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich. The ruling was part of the construction of patent claim terms in the patent infringement suit brought against Open Biosystems, Inc.

The lawsuit, which is pending in the U.S. District Court for the Eastern District of Missouri, alleges that Open Biosystems infringes U.S. Patent Nos. 6,924,123 and 7,056,699 entitled Lentiviral LTR Deleted Vector, which are owned by Oxford BioMedica and exclusively licensed to Sigma-Aldrich for research use, by selling, among other products, Open Biosystems' Lentiviral shRNAmir Library. In his order U.S. District Judge Charles A. Shaw concluded "that the constructions of the disputed terms and phrases proposed by plaintiff are correct."

Other news from the department politics & laws

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Low-carb diets linked to atherosclerosis and impaired blood vessel growth - Study suggests that popular diet regimen may have adverse effect on body's restorative capacity

Drug that modifies gene activity could help some older leukemia patients

Illumina and Wellcome Trust Sanger Institute Announce Completed Genome for Endangered Tasmanian Devil - Uncovering Mutations Found in Deadly Transmissible Cancer Could Help Conservation Efforts

Genetic enigma solved - Inheritance of coat color patterns in dogs

Genetic enigma solved - Inheritance of coat color patterns in dogs

A molecular map for the plant sciences - First comprehensive map of the proteome of the model plant Arabidopsis thaliana

A molecular map for the plant sciences - First comprehensive map of the proteome of the model plant Arabidopsis thaliana

Flying with fuel from sugarcane - A new promising biofuel feedstock

Thomson Reuters Predicts Nobel Laureates

How resistant cancer cells can be fought

How resistant cancer cells can be fought

Thermo Fisher Scientific Continues Investment in Global Manufacture of Bioprocessing Products - New Manufacturing Line in China Expands Production Capacity of Leading Thermo Scientific Bioprocessing Products in Europe, North America and Asia-Pacific

Can we promote healthy ageing of our cells? - The "firefighter" protein calls for the degradation of defective proteins

Can we promote healthy ageing of our cells? - The "firefighter" protein calls for the degradation of defective proteins

Inhibiting tumour-specific repair mechanisms - Findings can help to develop new or to improve existing strategies in cancer therapy

Inhibiting tumour-specific repair mechanisms - Findings can help to develop new or to improve existing strategies in cancer therapy

Prions can improve the health of fungal populations - Special proteins prevent fungi from infections by pathogens